CIBC Asset Management
NUVB icon

CIBC Asset Management’s Nuvation Bio NUVB Stock Holding History

CIBC Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.9K Sell
10,718
-3,683
-26% -$18K ﹤0.01% 1398
2026
Q1 		$61.8K Hold
14,401
– – ﹤0.01% 1338
2025
Q4 		$129K Buy
+14,401
New +$89.2K ﹤0.01% 1278

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CIBC Asset Management's NUVB Position: Q2 2026 in Review

CIBC Asset Management reduced its Nuvation Bio (NUVB) stake by 26% in Q2 2026, selling an estimated $18K and leaving 10,718 shares worth $60.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

CIBC Asset Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $129K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • CIBC Asset Management held 10,718 shares of Nuvation Bio worth $60.9K as of Q2 2026.
  • CIBC Asset Management sold 3,683 Nuvation Bio shares in Q2 2026, an estimated $18K.
  • Nuvation Bio made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1398 holding.
  • CIBC Asset Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • CIBC Asset Management's Nuvation Bio position peaked at $129K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.